Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has led to a surge in clinical trials evaluating investigational and approved drugs. Retrospective analysis of drugs taken by COVID-19 inpatients provides key information on drugs associated with better or worse outcomes. METHODS: We condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayat, Vafa, Ryono, Russell, Phelps, Steven, Geis, Eugene, Sedghi, Farshid, Etminani, Payam, Holodniy, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294673/
https://www.ncbi.nlm.nih.gov/pubmed/34307731
http://dx.doi.org/10.1093/ofid/ofab336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294673/
https://www.ncbi.nlm.nih.gov/pubmed/34307731
http://dx.doi.org/10.1093/ofid/ofab336

Ejemplares similares